2018 Q4 Form 10-Q Financial Statement

#000143774919002356 Filed on February 13, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2017 Q4
Revenue $1.904M $1.536M
YoY Change 23.96% 49.42%
Cost Of Revenue $1.139M $1.005M
YoY Change 13.33% -2.33%
Gross Profit $765.0K $531.0K
YoY Change 44.07% -53200.0%
Gross Profit Margin 40.18% 34.57%
Selling, General & Admin $1.803M $1.659M
YoY Change 8.68% 20.57%
% of Gross Profit 235.69% 312.43%
Research & Development $414.0K $340.0K
YoY Change 21.76% 126.67%
% of Gross Profit 54.12% 64.03%
Depreciation & Amortization $50.00K $40.00K
YoY Change 25.0% 100.0%
% of Gross Profit 6.54% 7.53%
Operating Expenses $2.194M $1.999M
YoY Change 9.75% 35.25%
Operating Profit -$1.429M -$1.468M
YoY Change -2.66% -0.74%
Interest Expense $15.00K $10.00K
YoY Change 50.0% -66.67%
% of Operating Profit
Other Income/Expense, Net $15.00K $5.000K
YoY Change 200.0% -82.76%
Pretax Income -$1.414M -$1.460M
YoY Change -3.15% 0.69%
Income Tax
% Of Pretax Income
Net Earnings -$1.414M -$1.463M
YoY Change -3.35% 0.9%
Net Earnings / Revenue -74.26% -95.25%
Basic Earnings Per Share
Diluted Earnings Per Share -$21.00K -$26.52K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.868M $5.680M
YoY Change 38.52% -52.47%
Cash & Equivalents $3.201M $2.951M
Short-Term Investments $0.00 $2.730M
Other Short-Term Assets $351.0K $300.0K
YoY Change 17.0% 36.36%
Inventory $494.0K $459.0K
Prepaid Expenses
Receivables $1.107M $990.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $9.820M $7.417M
YoY Change 32.4% -43.72%
LONG-TERM ASSETS
Property, Plant & Equipment $1.471M $1.168M
YoY Change 25.94% 49.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $173.0K $204.0K
YoY Change -15.2% -26.62%
Total Long-Term Assets $2.091M $1.961M
YoY Change 6.63% 8.58%
TOTAL ASSETS
Total Short-Term Assets $9.820M $7.417M
Total Long-Term Assets $2.091M $1.961M
Total Assets $11.91M $9.378M
YoY Change 27.01% -37.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.196M $580.0K
YoY Change 106.21% 87.1%
Accrued Expenses $444.0K $350.0K
YoY Change 26.86% -37.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.640M $931.0K
YoY Change 76.15% 6.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $606.0K $580.0K
YoY Change 4.48% 5.45%
Total Long-Term Liabilities $606.0K $580.0K
YoY Change 4.48% 5.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.640M $931.0K
Total Long-Term Liabilities $606.0K $580.0K
Total Liabilities $2.246M $1.507M
YoY Change 49.04% 6.28%
SHAREHOLDERS EQUITY
Retained Earnings -$82.27M -$75.61M
YoY Change 8.8% 8.97%
Common Stock $91.94M $83.49M
YoY Change 10.12% 0.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.665M $7.871M
YoY Change
Total Liabilities & Shareholders Equity $11.91M $9.378M
YoY Change 27.01% -37.42%

Cashflow Statement

Concept 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income -$1.414M -$1.463M
YoY Change -3.35% 0.9%
Depreciation, Depletion And Amortization $50.00K $40.00K
YoY Change 25.0% 100.0%
Cash From Operating Activities -$1.116M -$1.520M
YoY Change -26.58% -8.43%
INVESTING ACTIVITIES
Capital Expenditures -$115.0K -$100.0K
YoY Change 15.0% 11.11%
Acquisitions
YoY Change
Other Investing Activities $2.362M $570.0K
YoY Change 314.39% -2000.0%
Cash From Investing Activities $2.247M $480.0K
YoY Change 368.13% -500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -120.0K 40.00K
YoY Change -400.0% -500.0%
NET CHANGE
Cash From Operating Activities -1.116M -1.520M
Cash From Investing Activities 2.247M 480.0K
Cash From Financing Activities -120.0K 40.00K
Net Change In Cash 1.011M -1.000M
YoY Change -201.1% -44.13%
FREE CASH FLOW
Cash From Operating Activities -$1.116M -$1.520M
Capital Expenditures -$115.0K -$100.0K
Free Cash Flow -$1.001M -$1.420M
YoY Change -29.51% -9.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
156000
CY2018Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
175000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7298000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7671000
CY2017Q4 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
29000
isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
45000
isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
104000
CY2018Q4 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
395000
CY2017Q4 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
311000
isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
789000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
91868000
isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
163000
isr Noncash Financing Activities Warrants Issued
NoncashFinancingActivitiesWarrantsIssued
CY2015Q4 isr Purchase Agreement Period
PurchaseAgreementPeriod
P1Y
CY2018Q4 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
19000
isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
597000
CY2018Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
52000
CY2017Q4 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
0
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
87000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
33000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1196000
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1391000
CY2018Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
113000
CY2018Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
77000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84322000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
25000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
26000
CY2018Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
97000
CY2017Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
78000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
190000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
168000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10056000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3604000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
16000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
15000
CY2018Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
606000
CY2018Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
590000
CY2018Q4 us-gaap Assets
Assets
11911000
CY2018Q2 us-gaap Assets
Assets
7455000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
9820000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
5446000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3201000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2600000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2951000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2781000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6113000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3382000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3132000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
601000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2981000
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5830000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67331147
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56331147
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67331147
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56331147
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
67000
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
56000
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1139000
CY2017Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2177000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1951000
us-gaap Depreciation
Depreciation
65000
us-gaap Depreciation
Depreciation
36000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">New Accounting Pronouncements</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> &nbsp; Revenue Recognition, replacing guidance currently codified in Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> Revenue Recognition-Overall with various SEC Staff Accounting Bulletins providing interpretive guidance. The guidance establishes a new <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> step principle-based framework in an effort to significantly enhance comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets. The standard became effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of its fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company adopted the new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> and used the modified retrospective method. The adoption of ASU&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>&nbsp;did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the consolidated financial statements of the Company and did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significantly change the timing of revenue recognition compared to the previous methodology.&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> Leases (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>), which will require lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by most leases. The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years. Early adoption is permitted. The ASU will be effective for the Company in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> We are currently evaluating the impact of the guidance on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments. The update provides guidance on classification for cash receipts and payments related to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific issues. The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years, with early adoption permitted. The Company&nbsp;adopted&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 1, 2018. </div>The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted Cash&#x201d;.&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> is intended to clarify how entities present restricted cash in the statement of cash flows. The guidance requires entities to show the changes in the total of cash and cash equivalents and restricted cash in the statement of cash flows. As a result, entities will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer present transfers between cash and cash equivalents and restricted cash in the statement of cash flows. When cash and cash equivalents and restricted cash are presented in more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> line item on the balance sheet, the new guidance requires a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet. This reconciliation can be presented either on the face of the statement of cash flows or in the notes to the financial statements. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>and is to be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> This update resulted in an increase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$181,000</div> in cash, cash equivalents, and restricted cash at the beginning of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> period presented on the consolidated statement of cash flows.&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Other accounting standards that have been issued or proposed by FASB that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require adoption until a future date are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the consolidated financial statements upon adoption. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> discuss recent pronouncements that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</div></div>
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
120000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
155000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
566000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y18D
CY2017Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1101000
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
985000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2074000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1827000
CY2018Q4 us-gaap Gross Profit
GrossProfit
765000
CY2017Q4 us-gaap Gross Profit
GrossProfit
531000
us-gaap Gross Profit
GrossProfit
1289000
us-gaap Gross Profit
GrossProfit
796000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-195000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-49000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
23000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2018Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
23000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-35000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
27000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-53000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
36000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-32000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
18000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-106000
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-19000
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-15000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18000
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27000
CY2018Q4 us-gaap Inventory Net
InventoryNet
494000
CY2018Q2 us-gaap Inventory Net
InventoryNet
494000
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
266000
CY2018Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
319000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
379000
CY2018Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
371000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
97000
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
96000
CY2018Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
us-gaap Investment Income Interest
InvestmentIncomeInterest
25000
us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2018Q4 us-gaap Liabilities
Liabilities
2246000
CY2018Q2 us-gaap Liabilities
Liabilities
2425000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11911000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7455000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1640000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1835000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7370000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4043000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
164000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2726000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3184000
us-gaap Net Income Loss
NetIncomeLoss
-2922000
us-gaap Net Income Loss
NetIncomeLoss
-3010000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-1414000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1463000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1416000
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1466000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2927000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3015000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
2194000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
1999000
us-gaap Operating Expenses
OperatingExpenses
4236000
us-gaap Operating Expenses
OperatingExpenses
3816000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1429000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1468000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2947000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3020000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
173000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
225000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
150000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8259000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3554000
CY2018Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2000
CY2017Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
351000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
335000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7381000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4418000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3868000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8769000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8982000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1471000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1311000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1107000
CY2018Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1192000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
414000
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
340000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
834000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
701000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82270000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79348000
CY2018Q4 us-gaap Revenues
Revenues
1904000
CY2017Q4 us-gaap Revenues
Revenues
1536000
us-gaap Revenues
Revenues
3466000
us-gaap Revenues
Revenues
2747000
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
702000
CY2017Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
674000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1351000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1288000
us-gaap Share Based Compensation
ShareBasedCompensation
190000
us-gaap Share Based Compensation
ShareBasedCompensation
240000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2170000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.80
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
32000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
16875
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
70750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
76541
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
155000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
237500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3917000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.68
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
10000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
10000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3909000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.67
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y146D
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y21D
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y146D
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
4667000
CY2018Q2 us-gaap Short Term Investments
ShortTermInvestments
825000
CY2018Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82810
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82810
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
9665000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
5030000
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67331000
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55056000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66743000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55037000

Files In Submission

Name View Source Status
0001437749-19-002356-index-headers.html Edgar Link pending
0001437749-19-002356-index.html Edgar Link pending
0001437749-19-002356.txt Edgar Link pending
0001437749-19-002356-xbrl.zip Edgar Link pending
ex_133927.htm Edgar Link pending
ex_133928.htm Edgar Link pending
ex_133929.htm Edgar Link pending
ex_134564.htm Edgar Link pending
ex_134565.htm Edgar Link pending
ex_134566.htm Edgar Link pending
ex_134567.htm Edgar Link pending
ex_134568.htm Edgar Link pending
ex_134569.htm Edgar Link pending
ex_134570.htm Edgar Link pending
ex_134700.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20181231.xml Edgar Link completed
isr-20181231.xsd Edgar Link pending
isr-20181231_cal.xml Edgar Link unprocessable
isr-20181231_def.xml Edgar Link unprocessable
isr-20181231_lab.xml Edgar Link unprocessable
isr-20181231_pre.xml Edgar Link unprocessable
isr20181231_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending